Diabetic Macular Edema  >>  triamcinolone acetonide  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
triamcinolone acetonide / Generic mfg.
ACTRN12613000249752: The Use of Intravitreal Injection of Triamcinolone Acetonide in Diabetic Patients to Reduce Diabetic Macular Edema

Completed
4
19
 
suez canal university hospital, Suez Canal University Hospital
Diabetic macular edema
 
 
2004-005043-97: A Pilot study investigating the use of Intravitreal Triamcinolone prior to macular laser for Clinically Significant Diabetic Macular Oedema

Ongoing
4
50
Europe
Triamcinolone Acetonide, Kenalog, Kenalog
St Mary\'s NHS Trust
Macular oedema affects 29% of diabetic patients and is the main cause of visual impairment. Previous studies show that diffuse macular oedema carries a particularly poor prognosis despite laser photocoagulation.
 
 

Download Options